New eye drop for dry eye disease
Part of Eyes & vision clinical trials.
This study tests a new eye drop (5% VVN001) to treat dry eye disease that hasn't improved enough with artificial tears. It may help people with moderate-to-severe dry eye and low tear production.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 30 to 80 years old.
- You have dry eye disease in both eyes and have been using artificial tears for at least a month.
- In the past week, your eye dryness level was 5 out of 10 or higher.
- A doctor has confirmed your corneas have some damage from dryness (corneal staining score at least 6).
- Your tear production is low—between 1 and 7 millimeters on a 5-minute Schirmer test.
- You do not have uncontrolled glaucoma or recent glaucoma surgery.
- Women who can get pregnant must not be pregnant, nursing, or planning pregnancy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a new eye drop, JN002, can help people with dry eye disease. It checks if the drops improve symptoms and eye health over time.
This study tests whether RCI001, a new eye drop treatment, can help people with dry eye disease. If you've had dry eye symptoms for at least 6 months and are interested in trying a new treatment, this trial may be for you.
This trial tests a new eye drop called VSJ-110 to see if it is safe and effective for treating dry eye, compared to a placebo (inactive drops). It lasts 8 weeks and may help if you have dry eye symptoms.
This study tests an experimental eye drop made from human platelets (blood cells that help healing) for people with moderate to severe dry eye. The drop is compared to a placebo (fake drop) to see if it improves eye comfort and surface health.
This study tests a new eye drop (PRO-190) against a common artificial tear (Systane Ultra) to see how safe and comfortable it is. Healthy volunteers will use the drops and be monitored for any side effects or changes in their eyes.
This study tests an eye drop called OT202 for people with moderate to severe dry eye. It aims to see if it can help reduce dryness and improve eye comfort.
Hear when a new Dry Eye trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.